Reliance Life Sciences Private Limited recalls Bortezomib for Injection 3.5mg/Vial
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Sterility Assurance
- Products
-
- Bortezomib for Injection 3.5mg/Vial
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 11,400 vials
- About this recall
- Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01